يعرض 1 - 10 نتائج من 87 نتيجة بحث عن '"Christoph Kapitza"', وقت الاستعلام: 1.30s تنقيح النتائج
  1. 1
    Phase I studies of the safety, tolerability, pharmacokinetics and pharmacodynamics of the dual glucagon receptor/glucagon‐like peptide‐1 receptor agonist BI 456906

    المؤلفون: Arvid Jungnik, Jorge Arrubla Martinez, Leona Plum‐Mörschel, Christoph Kapitza, Daniela Lamers, Claus Thamer, Corinna Schölch, Michael Desch, Anita M. Hennige

    المصدر: Diabetes, Obesity and Metabolism. 25:1011-1023

    مصطلحات موضوعية: Endocrinology, Endocrinology, Diabetes and Metabolism, Internal Medicine

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::9876d7f877a459629520eae3aebc8be6Test
    https://doi.org/10.1111/dom.14948Test


    أضف إلى المفضلة
  2. 2
    Phase I studies of the safety, tolerability, pharmacokinetics and pharmacodynamics of the dual glucagon receptor/glucagon-like peptide-1 receptor (GCGR/GLP-1R) agonist BI 456906

    المؤلفون: Arvid, Jungnik, Jorge, Arrubla, Leona, Plum-Mörschel, Christoph, Kapitza, Daniela, Lamers, Claus, Thamer, Corinna, Schoelch, Michael, Desch, Anita M, Hennige

    المصدر: Diabetes, obesitymetabolism.

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid________::363d0794cb6f4d8649e4db2f3ce3c286Test
    https://pubmed.ncbi.nlm.nih.gov/36527386Test


    أضف إلى المفضلة
  3. 3
    Author response for 'Phase I studies of the safety, tolerability, pharmacokinetics and pharmacodynamics of the dual glucagon receptor/glucagon‐like peptide‐1 receptor ( GCGR / GLP‐1R ) agonist BI 456906'

    المؤلفون: null Arvid Jungnik, null Jorge Arrubla, null Leona Plum‐Mörschel, null Christoph Kapitza, null Daniela Lamers, null Claus Thamer, null Corinna Schoelch, null Michael Desch, null Anita M. Hennige

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::98723b5cc5f26b186448dcade1dbaad6Test
    https://doi.org/10.1111/dom.14948/v2/response1Test


    أضف إلى المفضلة
  4. 4
    Acute effects of linagliptin on intact and total glucagon‐like peptide‐1 and gastric inhibitory polypeptide levels in insulin‐dependent type 2 diabetes patients with and without moderate renal impairment

    المؤلفون: Juris J. Meier, Daniel R. Quast, Michael A. Nauck, Nina Schenker, Carolyn F. Deacon, Jens J. Holst, Leona Plum‐Mörschel, Christoph Kapitza

    المصدر: Meier, J J, Quast, D R, Nauck, M A, Schenker, N, Deacon, C F, Holst, J J, Plum-Mörschel, L & Kapitza, C 2022, ' Acute effects of linagliptin on intact and total glucagon-like peptide-1 and gastric inhibitory polypeptide levels in insulin-dependent type 2 diabetes patients with and without moderate renal impairment ', Diabetes, Obesity and Metabolism, vol. 24, no. 5, pp. 806-815 . https://doi.org/10.1111/dom.14636Test

    مصطلحات موضوعية: Blood Glucose, Endocrinology, Diabetes Mellitus, Type 2, Glucagon-Like Peptide 1, Endocrinology, Diabetes and Metabolism, Internal Medicine, Humans, Insulin, Linagliptin, Gastric Inhibitory Polypeptide

    وصف الملف: application/pdf

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ded496cd30437d5814892a737bef3683Test
    https://doi.org/10.1111/dom.14636Test


    أضف إلى المفضلة
  5. 5
    Ultra rapid lispro (URLi) shows faster pharmacokinetics and reduces postprandial glucose excursions versus H umalog® in patients with type 2 diabetes mellitus in a randomized, controlled crossover meal test early‐phase study

    المؤلفون: Christof M. Kazda, Jennifer Leohr, Thomas A. Hardy, Mary Anne Dellva, Christoph Kapitza, Mark Matzopoulos, Mei Teng Loh, Rong Liu, Shobha Reddy, Oliver Klein

    المصدر: Diabetes, Obesity and Metabolism. 24:187-195

    مصطلحات موضوعية: Blood Glucose, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, Pharmacology, Endocrinology, Pharmacokinetics, Internal Medicine, medicine, Humans, Hypoglycemic Agents, Insulin, Insulin lispro, Dosing, Cross-Over Studies, Insulin Lispro, business.industry, Postprandial Period, Crossover study, Diabetes Mellitus, Type 1, Glucose, Postprandial, Diabetes Mellitus, Type 2, Tolerability, Pharmacodynamics, business, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb4eef7c35470da7c8843e3c1b823e41Test
    https://doi.org/10.1111/dom.14561Test


    أضف إلى المفضلة
  6. 6
    A single‐dose euglycaemic clamp study in two cohorts to compare the exposure of SAR341402 (insulin aspart) Mix 70/30 with US ‐ and European‐ approved versions of insulin aspart Mix 70/30 and SAR341402 rapid‐acting solution in subjects with type 1 diabetes

    المؤلفون: Wolfgang Schmider, Bhaswati Mukherjee, Christoph Kapitza, Lenore Teichert, Irene Nowotny, Leszek Nosek

    المصدر: Diabetes, Obesity and Metabolism. 23:674-681

    مصطلحات موضوعية: medicine.medical_specialty, Type 1 diabetes, business.industry, Endocrinology, Diabetes and Metabolism, 030209 endocrinology & metabolism, 030204 cardiovascular system & hematology, medicine.disease, Crossover study, Confidence interval, Insulin aspart, 03 medical and health sciences, 0302 clinical medicine, Endocrinology, Pharmacokinetics, Internal medicine, Pharmacodynamics, Cohort, Internal Medicine, medicine, Dosing, business, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::78bdaafa2c988eb1e480252ceaa93718Test
    https://doi.org/10.1111/dom.14260Test


    أضف إلى المفضلة
  7. 7
    Author response for 'Acute effects of linagliptin on intact and total GLP ‐1 and GIP levels in insulin‐dependent type 2 diabetic patients with and without moderate renal impairment'

    المؤلفون: null Juris J. Meier, null Daniel R. Quast, null Michael A. Nauck, null Nina Schenker, null Carolyn F. Deacon, null Jens J. Holst, null Leona Plum‐Mörschel, null Christoph Kapitza

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d202926564bbd71ab4bc3ef19f7a60b3Test
    https://doi.org/10.1111/dom.14636/v3/response1Test


    أضف إلى المفضلة
  8. 8
    Author response for 'Effect of upper gastrointestinal disease on the pharmacokinetics of oral semaglutide in subjects with type 2 diabetes'

    المؤلفون: null Juris J. Meier, null Charlotte Granhall, null Ulrike Hoevelmann, null Andrea Navarria, null Leona Plum‐Moerschel, null Chethana Ramesh, null Andrea Tannapfel, null Christoph Kapitza

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::6e7094bb2c3e95b57dba93a1d767520cTest
    https://doi.org/10.1111/dom.14632/v2/response1Test


    أضف إلى المفضلة
  9. 9
    Ultra rapid lispro lowers postprandial glucose and more closely matches normal physiological glucose response compared to other rapid insulin analogues: A phase 1 randomized, crossover study

    المؤلفون: Eric Zijlstra, Christoph Kapitza, Qianyi Zhang, Helle Linnebjerg, Juliana M. Bue-Valleskey, David E. Coutant, Jennifer Leohr, Tim Heise, Elizabeth Smith Labell, Mary Anne Dellva

    المصدر: Diabetes, Obesity & Metabolism

    مصطلحات موضوعية: Blood Glucose, medicine.medical_specialty, Glucose control, type 1 diabetes, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, insulin analogues, 030209 endocrinology & metabolism, 030204 cardiovascular system & hematology, 03 medical and health sciences, 0302 clinical medicine, Endocrinology, Pharmacokinetics, Internal medicine, Internal Medicine, medicine, pharmacodynamics, randomized trial, Humans, Hypoglycemic Agents, Insulin, In patient, Type 1 diabetes, Cross-Over Studies, Insulin Lispro, business.industry, Original Articles, medicine.disease, Crossover study, Postprandial, glycaemic control, Diabetes Mellitus, Type 1, Glucose, Original Article, Insulin absorption, business, pharmacokinetics

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5389cfce7345fb4921d7a00fbf48d12cTest
    http://europepmc.org/articles/PMC7540588Test


    أضف إلى المفضلة
  10. 10
    Single-Dose Euglycemic Clamp Study Demonstrating Pharmacokinetic and Pharmacodynamic Similarity Between SAR341402 Insulin Aspart and US- and EU-Approved Versions of Insulin Aspart in Subjects with Type 1 Diabetes

    المؤلفون: Christoph Kapitza, Lenore Teichert, Irene Nowotny, Leszek Nosek, Wolfgang Schmider

    المصدر: Diabetes Technology & Therapeutics

    مصطلحات موضوعية: Adult, Blood Glucose, Male, Adolescent, endocrine system diseases, Endocrinology, Diabetes and Metabolism, 030209 endocrinology & metabolism, Pharmacology, Insulin aspart, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Endocrinology, Double-Blind Method, Pharmacokinetics, Diabetes mellitus, medicine, Humans, Hypoglycemic Agents, European Union, 030212 general & internal medicine, Biosimilar Pharmaceuticals, Aged, Type 1 diabetes, Cross-Over Studies, business.industry, Biosimilar, nutritional and metabolic diseases, Original Articles, Middle Aged, medicine.disease, United States, Phase i study, Medical Laboratory Technology, Diabetes Mellitus, Type 1, Treatment Outcome, Pharmacodynamics, Phase I study, Glucose Clamp Technique, business, hormones, hormone substitutes, and hormone antagonists, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::835b87dcd9ea09245d748d78b896ec2bTest
    https://doi.org/10.1089/dia.2019.0351Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث